SciSparc Stock Price

-0.005 (-0.22%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 41,130
Bid Price 2.00
Ask Price 2.39
News -
Day High 2.29


52 Week Range


Day Low 2.0451
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
SciSparc Ltd SPRC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.005 -0.22% 2.23 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.17 2.0451 2.29 2.23 2.235
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
211 41,130 $ 2.23 $ 91,917 - 1.80 - 7.08
Last Trade Time Type Quantity Stock Price Currency
19:21:48 1 $ 2.23 USD


Draw Mode:

SciSparc Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 7.12M 3.19M 3.18M $ - $ - -2.83 -0.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

SciSparc News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SPRC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.832.39821.832.0897,8290.4021.86%
1 Month3.063.63481.802.90201,503-0.83-27.12%
3 Months3.553.94991.803.10847,646-1.32-37.18%
6 Months6.957.081.803.36474,189-4.72-67.91%
1 Year7.007.081.803.36466,754-4.77-68.14%
3 Years7.007.081.803.36466,754-4.77-68.14%
5 Years7.007.081.803.36466,754-4.77-68.14%

SciSparc Description

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220628 05:38:54